Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2019 | 27 |

Tytuł artykułu

Assessment of the knowledge about HIV-infectious materials in Poland

Treść / Zawartość

Warianty tytułu

Języki publikacji



Malignancies were one of the earliest diagnosed manifestations that resulted in the description of acquired immunodeficiency syndrome (AIDS). Most cancers in AIDS patients are associated with coinfection with oncogenic viruses. Knowledge and public awareness about HIV infectious materials are important elements in preventing the spread of HIV infections. The aim of the study was to assess the knowledge about HIV infectious materials among three populations in Poland. A Poland-wide online survey was conducted and 2205 anonymous answers were analysed. Almost half of the answers came from students, of which 40% were medical students.

Słowa kluczowe






Opis fizyczny



  • Department of Infectious Diseases and Hepatology, Medical University of Silesia, Bytom, Poland
  • Department of Infectious Diseases and Hepatology, Medical University of Silesia, Bytom, Poland
  • Department of Infectious Diseases and Hepatology, Medical University of Silesia, Bytom, Poland


  • [1] Faria NR, Rambaut A, Suchard MA, Baele G, Bedford T, Ward MJ, Tatem AJ, Sousa JD, Arinaminpathy N, Pépin J, Posada D, Peeters M, Pybus OG, Lemey P. HIV epidemiology. The early spread and epidemic ignition of HIV 1 in human populations. Science 346 (2014) 56-61.
  • [2] Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV 1. Science 313 (2006) 523-526.
  • [3] Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305(24) (1981) 1425-31.
  • [4] Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352 (1998) 1725-1730.
  • [5] Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860.
  • [6] Vittinghoff E, Scheer S, O’Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis 179 (1999) 717-720.
  • [7] Antiretroviral Therapy Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in highincome countries: a collaborative analysis of 14 cohort studies. Lancet 372 (2008) 293-299.
  • [8] Baeten JM, Kahle E, Lingappa JR, Coombs RW, DelanyMoretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3(77) (2011) 77ra29.
  • [9] Sheth PM, Kovacs C, Kemal KS, Jones RB, Raboud JM, Pilon R, la Porte C, Ostrowski M, Loutfy M, Burger H et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 23 (2009) 2050-2054.
  • [10] Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 21 (2007) 501-507.
  • [11] Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23 (2009) 1397-1404.
  • [12] Vangipuram R, Tyring SK. AIDS-Associated Malignancies. Cancer Treat Res 177 (2019) 1-21.
  • [13] Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 297 (1988) 1363-1368.
  • [14] Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324 (1991) 954-960.
  • [15] Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125 (1996) 257-264.
  • [16] Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. Viral dynamics of acute HIV-1 infection. J Exp Med 190 (1999) 841-850.
  • [17] Lindback S, Karlsson AC, Mittler J, Blaxhult A, Carlsson M, Briheim G, Sonnerborg A, Gaines H. Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS 14 (2000a) 2283-2291.
  • [18] Lindback S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, Blaxhult A, Sonnerborg A, Biberfeld G, Gaines H. Diagnosis of primary HIV-1 infection and duration of follow-up after HIVexposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 14 (2000b) 2333-2339.
  • [19] Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci 105 (2008) 7552-7557.
  • [20] Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, SalazarGonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, et al. Modeling sequence evolution in acute HIV-1 infection. J Theor Biol 261 (2009) 341-360.
  • [21] McKenzie R, Travis WD, Dolan SA, Pittaluga S, Feuerstein IM, Shelhamer J, et al. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 70(5) (1991) 326‐343.
  • [22] Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV‐ infected people in the United States. J Natl Cancer Inst 107(4) (2015).
  • [23] Kaposi's Sarcoma. Source: National Cancer Institute. Available at:

Typ dokumentu



Identyfikator YADDA

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.